Human leukocyte antigen matching in renal transplantation: An update

Current Opinion in Nephrology and Hypertension

Volumn 9, Issue 6, 2000, Pages 683-687

  Goes, Nelson ^a   Chandraker, Anil ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA ANTIBODY; HLA ANTIGEN; HLA B ANTIGEN; IMMUNOSUPPRESSIVE AGENT;

CADAVER DONOR; CROSS REACTION; DIAGNOSTIC ACCURACY; GRAFT REJECTION; GRAFT SURVIVAL; HEALTH CARE POLICY; HLA MATCHING; HUMAN; KIDNEY ALLOGRAFT; KIDNEY DONOR; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING;

ANTIBODIES; CROSS REACTIONS; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; KIDNEY TRANSPLANTATION;

EID: 0033677562     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200011000-00015     Document Type: Review

References (36)

1. Improved graft survival after renal transplantation in the United States, 1988 to 1996
2. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant
3. Impact of acute rejection and early allograft function on renal allograft survival
4. Clinical correlates of chronic rejection in pediatric renal transplantation. A report of the North American Pediatric Renal Transplant Cooperative Study
5. Occurrence of cytotoxic and noncomplement fixing antibodies in the crossmatch serum of patients with early acute rejection episodes
6. The clinical importance of choosing the right assay for the detection of HLA-specific donor reactive antibodies
7. Selective omission of the donor crossmatch before renal transplantation: Efficacy, safety and effects on cold storage time
8. Clinical relevance of anti-HLA antibodies pre and post transplant
9. The alloimmunized patient: Monitoring and therapeutics
10. The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection
11. The significance of the anticlass I response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody
12. Pathologic features of acute renal allograft rejection associated with donor-specific antibody. Analysis using the Banff grading schema
13. Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation
14. Effects of changes in the criteria for nationally shared kidney transplants for HLA-matched patients
15. The national impact of the 1995 changes to the UNOS renal allocation system. United Network for Organ Sharing
16. Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK. HLA Task Force of the Kidney Advisory Group of the United Kingdom Transplant Support Service Authority (UKTSSA)
17. The allocation of cadaver kidneys for transplantation in the United States: Consensus and controversy. ASN Transplant Advisory Group. American Society of Nephrology
18. The effect of patients' preferences on racial differences in access to renal transplantation
19. How should cadaver kidneys be allocated?
20. Cadaver kidneys: The rules of rationing
21. The allocation of cadaveric kidneys
22. Allocation of kidneys for renal transplantation
23. Allocation of cadaver kidneys. The UKTSSA Users Kidney Advisory Group Audit Subcommittee
24. Eurotransplant kidney allocation
25. The economic implications of HLA matching in cadaveric renal transplantation
26. The politics of grafting cadaver
27. The economic implications of HLA matching in cadaveric renal transplantation
28. Analysis of HLA-DR matching in DNA-typed cadaver kidney transplants
29. Factors contributing to long-term kidney graft survival in Eurotransplant
30. Allocation of cadaver kidneys
31. Association between specific HLA combinations and probability of kidney allograft loss: The taboo concept
32. Sharing cross-reactive groups of MHC class I improves long-term graft survival
33. Evaluation of HLA matching for CREG antigens in Europe
34. Differences in anti-CREG antibody formation between transplanted and non-transplanted renal patients
35. Effect of HLA mismatch in African-Americans
36. Is HLA matching worth the effort?